The mission of NanoReMedi is to define a joint doctorate educational training model in Functional nano-scaffolds for regenerative medicine where Acadimia and Industry join their forces to:
- create a highly innovative research network for training a new generation of researchers who will enter the area of nanoscience from adjacent disciplines (such as chemistry, material sciences and bioinformatics)
- establish a solid framework for long-term research cooperation between a pool of leading Universities and Enterprises
- build a solid foundation for long-term European excellence in medical nanotechnology
NanoReMedi project promotes institutional Cooperation and Mobility of 13 early stage researchers.
The NanoReMedi consortium is strongly multidisciplinary and takes advantage of a number of different state-of-the-art technologies and methodologies:
• Computational chemistry
• Chemical synthesis/peptide synthesis
• Peptide based Nanomaterials production and characterization
The research project aims to repair or replace tissue and organ functions lost due to age, disease or damage represents one of the most urgent medical needs of our aging society. The NanoReMedi scientific approach relies on the design, preparation, characterization and validation of innovative peptide-based functional nanomaterials for regenerative medicine applications. NanoReMedi tackles three highly relevant case studies:
• Tissue engineered vascular grafts to replace damaged peripheral arteries
• Stem-cell based regenerative medicine for bone and cartilage repair
• Facing with implantation failure due to bacterial severe infections. to train a new generation of researchers in nanoscience to establish a framework for long-term research cooperation between leading Universities and Enterprises to build up long-term European excellence in nanotechnology
This project has received funding from the European Union’s research and innovation programme under the Marie Skłodowska-Curie grant agreement No 101072645.